Elizabeth Zarate-Rowell
Psychiatry · Seal Beach, CANPI 1992830236
Payments from drug & device makers
Across 1,519 payments — averaging $2539.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.1M
- Teva Pharmaceuticals USA, Inc.$569K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$320K
- H. Lundbeck A S$309K
- Acadia Pharmaceuticals Inc$242K
- Boehringer Ingelheim$232K
- plus $1.1M from 31 others
Across 14 payments — averaging $249.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Acadia Pharmaceuticals Inc$1K
- Eli Lilly$438
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,857,289 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Seal Beach
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.